440 related articles for article (PubMed ID: 30115454)
21. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.
Rueth NM; Black DM; Limmer AR; Gabriel E; Huo L; Fornage BD; Dogan BE; Chavez-MacGregor M; Yi M; Hunt KK; Strom EA
Ann Surg Oncol; 2015 Jan; 22(1):90-5. PubMed ID: 25249256
[TBL] [Abstract][Full Text] [Related]
22. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
[TBL] [Abstract][Full Text] [Related]
23. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
24. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
[TBL] [Abstract][Full Text] [Related]
25. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy.
Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB
Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599
[TBL] [Abstract][Full Text] [Related]
27. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer.
Cefaro GA; Genovesi D; Trignani M; DI Nicola M
Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361
[TBL] [Abstract][Full Text] [Related]
28. Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study.
Jacob J; Belin L; Pierga JY; Gobillion A; Vincent-Salomon A; Dendale R; Beuzeboc P; Campana F; Fourquet A; Kirova YM
Breast Cancer Res Treat; 2014 Nov; 148(2):345-53. PubMed ID: 25318926
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
30. Medial tumor localization in breast cancer--an unappreciated risk factor?
Bräutigam E; Track C; Seewald DH; Feichtinger J; Spiegl K; Hammer J
Strahlenther Onkol; 2009 Oct; 185(10):663-8. PubMed ID: 19806331
[TBL] [Abstract][Full Text] [Related]
31. The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.
Park TS; Thomas SM; Rosenberger LH; Fayanju OM; Plichta JK; Blitzblau RC; Ong CT; Hyslop T; Hwang ES; Greenup RA
Ann Surg Oncol; 2018 Oct; 25(10):3019-3029. PubMed ID: 29978365
[TBL] [Abstract][Full Text] [Related]
32. Tumor characteristics and therapy of elderly patients with breast cancer.
Grumpelt AM; Ignatov A; Tchaikovski SN; Burger E; Costa SD; Eggemann H
J Cancer Res Clin Oncol; 2016 May; 142(5):1109-16. PubMed ID: 26809246
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy after breast-conservation surgery: how much is enough?
Deutsch M
Semin Surg Oncol; 1992; 8(3):140-6. PubMed ID: 1496224
[TBL] [Abstract][Full Text] [Related]
34. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
Poortmans PM; Collette S; Kirkove C; Van Limbergen E; Budach V; Struikmans H; Collette L; Fourquet A; Maingon P; Valli M; De Winter K; Marnitz S; Barillot I; Scandolaro L; Vonk E; Rodenhuis C; Marsiglia H; Weidner N; van Tienhoven G; Glanzmann C; Kuten A; Arriagada R; Bartelink H; Van den Bogaert W;
N Engl J Med; 2015 Jul; 373(4):317-27. PubMed ID: 26200978
[TBL] [Abstract][Full Text] [Related]
35. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
Daveau C; Stevens D; Brain E; Berges O; Villette S; Moisson P; Gardner M; De la Lande B; Lasry S; Labib A; Le Scodan R
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):337-42. PubMed ID: 20171795
[TBL] [Abstract][Full Text] [Related]
36. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.
Sosa JA; Diener-West M; Gusev Y; Choti MA; Lange JR; Dooley WC; Zeiger MA
Ann Surg Oncol; 1998 Mar; 5(2):140-9. PubMed ID: 9527267
[TBL] [Abstract][Full Text] [Related]
37. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
[TBL] [Abstract][Full Text] [Related]
38. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.
Hunt KK; Ballman KV; McCall LM; Boughey JC; Mittendorf EA; Cox CE; Whitworth PW; Beitsch PD; Leitch AM; Buchholz TA; Morrow MA; Giuliano AE
Ann Surg; 2012 Sep; 256(3):428-36. PubMed ID: 22868365
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
